1 treatment center
No centers match
Try a different search term
1 SAMHSA-listed treatment center in Kinston, North Carolina. Free, confidential help available 24/7 — most callers reach a licensed counselor in under 60 seconds.
Try a different search term
Free, confidential assistance matching you with the right program in Kinston.
Kinston, North Carolina has 1 SAMHSA-verified addiction treatment center offering 1 outpatient. Each facility listed here is verified through the Substance Abuse and Mental Health Services Administration (SAMHSA) and provides evidence-based treatment approaches.
Outpatient programs allow Kinston residents to receive treatment while maintaining their daily responsibilities. Sessions are typically scheduled 3-5 days per week, making it possible to continue working or attending school.
Treatment centers in Kinston accept most major insurance plans including Medicaid, Medicare, Blue Cross Blue Shield, Aetna, Cigna, and UnitedHealthcare. Many facilities also offer sliding scale fees and payment plans. Call (319) 271-2077 to verify your coverage before admission.
Patients in Kinston without insurance, or with insurance whose substance-use benefits fall short, have several alternatives: state-funded treatment slots (limited capacity, often with waitlists); Federally Qualified Health Centers providing outpatient addiction services on income-based sliding scales; faith-based residential programs that operate on charitable funding; and 12-step-based community recovery support that operates outside the formal treatment system. The SAMHSA National Helpline (1-800-662-HELP) can navigate uninsured patients to appropriate options in or near Kinston.
Pregnant women in Kinston with active substance use should not stop opioid use abruptly if dependent — withdrawal during pregnancy carries fetal risk including preterm labor and stillbirth. Evidence-based care is buprenorphine or methadone maintenance (NOT detox), continued through pregnancy and postpartum. North Carolina maternal-fetal medicine specialists, OB-GYNs trained in addiction medicine, and SAMHSA's Center of Excellence for Pregnant and Postpartum Women with Opioid Use Disorder provide specialized care pathways for this population.
Medication-assisted treatment (MAT) for opioid use disorder is available in Kinston through multiple pathways: federally certified Opioid Treatment Programs (OTPs) dispensing methadone, office-based buprenorphine prescribers (now expanded after the X-waiver elimination), and extended-release naltrexone (Vivitrol) at clinics willing to administer the monthly injection. Each medication has clinical use cases — methadone for severe long-standing opioid use disorder, buprenorphine for outpatient maintenance, naltrexone for patients fully detoxed and committed to abstinence-based recovery.
Kinston sits within North Carolina's broader addiction-treatment infrastructure — a network of licensed providers ranging from medically supervised detox facilities through residential treatment, partial hospitalization, intensive outpatient, and standard outpatient counseling. Patients seeking care in Kinston have access to options at multiple intensity levels, with placement decisions driven by ASAM criteria: withdrawal risk, biomedical conditions, emotional/behavioral status, readiness to change, relapse potential, and the patient's current recovery environment. The specific providers verified for Kinston below represent facilities that have been confirmed against SAMHSA's treatment-locator database and North Carolina licensing records.
Recovery coaching is an emerging aftercare modality in Kinston and broadly across the U.S. Recovery coaches — typically people in long-term recovery, trained and credentialed through state-recognized programs — provide individualized recovery support outside the clinical framework. Functions include navigation of community resources, accountability, advocacy, and peer support. Some Medicaid programs in North Carolina now reimburse for recovery-coach services, expanding access for patients without commercial insurance.
Anxiety disorders complicate addiction recovery for many Kinston patients, particularly in early recovery when anxiety symptoms often intensify without the substance previously used to suppress them. Treatment approaches include cognitive-behavioral therapy specifically for anxiety, judicious psychiatric medication management (avoiding benzodiazepines for most patients in addiction recovery given the dependence risk), structured exposure work, mindfulness-based interventions, and lifestyle interventions (sleep, exercise, caffeine moderation) that compound the formal treatment effects.
Patients arriving at Kinston residential facilities should expect a medical evaluation within hours of admission: vital signs, withdrawal-symptom assessment using validated scales (CIWA for alcohol, COWS for opioids), medication reconciliation with the patient's prescribing providers, and physical examination by nursing or physician staff. Medical stabilization takes priority over therapeutic programming during this early phase — patients in active withdrawal aren't expected to engage in group therapy until stabilization is achieved.